Rank | Gene Set | Z-score |
---|---|---|
1 | vocalization behavior (GO:0071625) | 5.53028367 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.47748852 |
3 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.39566845 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.38465240 |
5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.25627548 |
6 | neuron cell-cell adhesion (GO:0007158) | 5.25093376 |
7 | synaptic vesicle exocytosis (GO:0016079) | 5.22833722 |
8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.95771765 |
9 | protein localization to synapse (GO:0035418) | 4.91463612 |
10 | glutamate receptor signaling pathway (GO:0007215) | 4.86910256 |
11 | locomotory exploration behavior (GO:0035641) | 4.80444402 |
12 | neuron-neuron synaptic transmission (GO:0007270) | 4.61495075 |
13 | synaptic transmission, glutamatergic (GO:0035249) | 4.60537877 |
14 | glutamate secretion (GO:0014047) | 4.59886831 |
15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.59837435 |
16 | synaptic vesicle maturation (GO:0016188) | 4.52556332 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.50966424 |
18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.50760756 |
19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.44594046 |
20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.44234528 |
21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.39315909 |
22 | response to histamine (GO:0034776) | 4.33884846 |
23 | exploration behavior (GO:0035640) | 4.28953192 |
24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.21445238 |
25 | regulation of synapse structural plasticity (GO:0051823) | 4.17282153 |
26 | neuron recognition (GO:0008038) | 4.12330320 |
27 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.11793385 |
28 | neuronal action potential propagation (GO:0019227) | 4.11057980 |
29 | regulation of synaptic vesicle transport (GO:1902803) | 4.07003434 |
30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.00657281 |
31 | neurotransmitter secretion (GO:0007269) | 3.94408912 |
32 | long-term synaptic potentiation (GO:0060291) | 3.91030992 |
33 | regulation of postsynaptic membrane potential (GO:0060078) | 3.88745109 |
34 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.87027106 |
35 | presynaptic membrane assembly (GO:0097105) | 3.86609243 |
36 | behavioral response to cocaine (GO:0048148) | 3.79926096 |
37 | prepulse inhibition (GO:0060134) | 3.79399048 |
38 | long-term memory (GO:0007616) | 3.79325584 |
39 | axonal fasciculation (GO:0007413) | 3.76144970 |
40 | positive regulation of membrane potential (GO:0045838) | 3.75421109 |
41 | behavioral fear response (GO:0001662) | 3.73972791 |
42 | behavioral defense response (GO:0002209) | 3.73972791 |
43 | regulation of synaptic plasticity (GO:0048167) | 3.72168009 |
44 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.72154283 |
45 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.71318790 |
46 | dendritic spine morphogenesis (GO:0060997) | 3.70272838 |
47 | positive regulation of synapse maturation (GO:0090129) | 3.70260127 |
48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.69767266 |
49 | synaptic transmission, dopaminergic (GO:0001963) | 3.67539891 |
50 | membrane depolarization during action potential (GO:0086010) | 3.67215597 |
51 | postsynaptic membrane organization (GO:0001941) | 3.65300949 |
52 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.64007507 |
53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.63992881 |
54 | gamma-aminobutyric acid transport (GO:0015812) | 3.63523388 |
55 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.60632684 |
56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.60092472 |
57 | presynaptic membrane organization (GO:0097090) | 3.59393158 |
58 | cellular potassium ion homeostasis (GO:0030007) | 3.58978661 |
59 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.58355292 |
60 | serotonin metabolic process (GO:0042428) | 3.58115586 |
61 | layer formation in cerebral cortex (GO:0021819) | 3.51945135 |
62 | synaptic vesicle endocytosis (GO:0048488) | 3.50572977 |
63 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.50135626 |
64 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.48488716 |
65 | transmission of nerve impulse (GO:0019226) | 3.47781332 |
66 | regulation of glutamate secretion (GO:0014048) | 3.47427393 |
67 | striatum development (GO:0021756) | 3.46296435 |
68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.43163481 |
69 | fear response (GO:0042596) | 3.42655500 |
70 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.41909046 |
71 | regulation of female receptivity (GO:0045924) | 3.38326561 |
72 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.37795549 |
73 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.37795549 |
74 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35236612 |
75 | learning (GO:0007612) | 3.34757799 |
76 | startle response (GO:0001964) | 3.34133985 |
77 | innervation (GO:0060384) | 3.32802798 |
78 | response to amphetamine (GO:0001975) | 3.31186699 |
79 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.29930440 |
80 | female mating behavior (GO:0060180) | 3.25693409 |
81 | neurotransmitter transport (GO:0006836) | 3.25203334 |
82 | membrane depolarization (GO:0051899) | 3.23455389 |
83 | auditory behavior (GO:0031223) | 3.23045001 |
84 | dopamine receptor signaling pathway (GO:0007212) | 3.21071176 |
85 | long term synaptic depression (GO:0060292) | 3.19987274 |
86 | regulation of dendritic spine development (GO:0060998) | 3.18169290 |
87 | proline transport (GO:0015824) | 3.15091748 |
88 | synapse assembly (GO:0007416) | 3.14845536 |
89 | nucleobase catabolic process (GO:0046113) | 3.14823869 |
90 | regulation of neurotransmitter secretion (GO:0046928) | 3.14209931 |
91 | primary amino compound metabolic process (GO:1901160) | 3.13908665 |
92 | regulation of vesicle fusion (GO:0031338) | 3.12886263 |
93 | behavioral response to nicotine (GO:0035095) | 3.12146645 |
94 | activation of protein kinase A activity (GO:0034199) | 3.10577600 |
95 | positive regulation of synaptic transmission (GO:0050806) | 3.10387178 |
96 | positive regulation of dendritic spine development (GO:0060999) | 3.08792747 |
97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08002837 |
98 | regulation of neurotransmitter transport (GO:0051588) | 3.06467713 |
99 | dendritic spine organization (GO:0097061) | 3.05649973 |
100 | response to auditory stimulus (GO:0010996) | 3.03424463 |
101 | synaptic transmission (GO:0007268) | 3.02914628 |
102 | regulation of neurotransmitter uptake (GO:0051580) | 3.02861288 |
103 | L-amino acid import (GO:0043092) | 3.02767989 |
104 | negative regulation of dendrite development (GO:2000171) | 3.02673023 |
105 | regulation of neurotransmitter levels (GO:0001505) | 3.02538980 |
106 | regulation of synaptic transmission (GO:0050804) | 3.02372312 |
107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.01642347 |
108 | mechanosensory behavior (GO:0007638) | 3.00903593 |
109 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00531270 |
110 | membrane hyperpolarization (GO:0060081) | 2.99268806 |
111 | regulation of synapse maturation (GO:0090128) | 2.97699593 |
112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.96472930 |
113 | dendrite morphogenesis (GO:0048813) | 2.95907259 |
114 | axon ensheathment in central nervous system (GO:0032291) | 2.93403553 |
115 | central nervous system myelination (GO:0022010) | 2.93403553 |
116 | neuronal action potential (GO:0019228) | 2.92854471 |
117 | sodium ion export (GO:0071436) | 2.87858195 |
118 | adaptation of signaling pathway (GO:0023058) | 2.84946888 |
119 | cerebellar granule cell differentiation (GO:0021707) | 2.82013321 |
120 | adult walking behavior (GO:0007628) | 2.81576291 |
121 | neuromuscular synaptic transmission (GO:0007274) | 2.81469519 |
122 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.80437632 |
123 | neuronal ion channel clustering (GO:0045161) | 2.79256294 |
124 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.77919714 |
125 | neurotransmitter uptake (GO:0001504) | 2.77130461 |
126 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.75597027 |
127 | regulation of collateral sprouting (GO:0048670) | 2.73581427 |
128 | positive regulation of synapse assembly (GO:0051965) | 2.71907456 |
129 | central nervous system neuron axonogenesis (GO:0021955) | 2.71841094 |
130 | glycosphingolipid biosynthetic process (GO:0006688) | 2.71783204 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.25396671 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06546707 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21036946 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.11040620 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05933953 |
6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72684530 |
7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69863619 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65897123 |
9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65897123 |
10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.61832117 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.61375683 |
12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.61162831 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55834624 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51689083 |
15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40069359 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39839070 |
17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.31377302 |
18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28707216 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.17558233 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17297435 |
21 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15612395 |
22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15193021 |
23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14879008 |
24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14008981 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12375175 |
26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.05015512 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01085105 |
28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99185378 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97793899 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94174138 |
31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87285319 |
32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85480750 |
33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78696699 |
34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75830652 |
35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74096519 |
36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.73344687 |
37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72407422 |
38 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60436123 |
39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57879814 |
40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54659398 |
41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52327537 |
42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49714488 |
43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49328587 |
44 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46184415 |
45 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.45548358 |
46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45177236 |
47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42665083 |
48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39574229 |
49 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.39418753 |
50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38437318 |
51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37883116 |
52 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35795330 |
53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35309563 |
54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34483554 |
55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33985260 |
56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.33741019 |
57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33224712 |
58 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32690140 |
59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31305958 |
60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30961520 |
61 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30713606 |
62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28025223 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26216098 |
64 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23912086 |
65 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22283465 |
66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21624664 |
67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20947140 |
68 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19100512 |
69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17436938 |
70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14140862 |
71 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13673736 |
72 | AR_19668381_ChIP-Seq_PC3_Human | 1.12824868 |
73 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12719710 |
74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12671778 |
75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12488155 |
76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12368685 |
77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12368685 |
78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11957602 |
79 | JUN_21703547_ChIP-Seq_K562_Human | 1.08279628 |
80 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.07648747 |
81 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06900975 |
82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06224155 |
83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05740439 |
84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04870965 |
85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04687902 |
86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03958279 |
87 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03954159 |
88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03525953 |
89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03454765 |
90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03259713 |
91 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.03208491 |
92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02425958 |
93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02425958 |
94 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02047313 |
95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02016193 |
96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01778634 |
97 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01409723 |
98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01333728 |
99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01172869 |
100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01038236 |
101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00891626 |
102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00287532 |
103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00167438 |
104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99899213 |
105 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99719780 |
106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99245758 |
107 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.98812466 |
108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96003082 |
109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96001835 |
110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95020826 |
111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.94402221 |
112 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.93825683 |
113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.93141352 |
114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92452317 |
115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91173788 |
116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91088489 |
117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90998024 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.51411721 |
2 | MP0003880_abnormal_central_pattern | 5.76544377 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.21522951 |
4 | MP0004270_analgesia | 3.61443713 |
5 | MP0009745_abnormal_behavioral_response | 3.59542999 |
6 | MP0002063_abnormal_learning/memory/cond | 3.59456520 |
7 | MP0002064_seizures | 3.14654062 |
8 | MP0001968_abnormal_touch/_nociception | 3.12584441 |
9 | MP0002822_catalepsy | 3.08735968 |
10 | MP0002572_abnormal_emotion/affect_behav | 3.03841107 |
11 | MP0009046_muscle_twitch | 2.71938718 |
12 | MP0002736_abnormal_nociception_after | 2.66558439 |
13 | MP0001486_abnormal_startle_reflex | 2.60541257 |
14 | MP0002272_abnormal_nervous_system | 2.53457609 |
15 | MP0005423_abnormal_somatic_nervous | 2.42189991 |
16 | MP0001440_abnormal_grooming_behavior | 2.40105613 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.38618691 |
18 | MP0002735_abnormal_chemical_nociception | 2.27674271 |
19 | MP0001501_abnormal_sleep_pattern | 2.27503601 |
20 | MP0001529_abnormal_vocalization | 2.22779907 |
21 | MP0000778_abnormal_nervous_system | 2.03623417 |
22 | MP0002067_abnormal_sensory_capabilities | 1.96800762 |
23 | MP0002733_abnormal_thermal_nociception | 1.95367009 |
24 | MP0003787_abnormal_imprinting | 1.93254564 |
25 | MP0001970_abnormal_pain_threshold | 1.89407343 |
26 | MP0002184_abnormal_innervation | 1.82761858 |
27 | MP0005646_abnormal_pituitary_gland | 1.82507364 |
28 | MP0001905_abnormal_dopamine_level | 1.79462514 |
29 | MP0004924_abnormal_behavior | 1.77527205 |
30 | MP0005386_behavior/neurological_phenoty | 1.77527205 |
31 | MP0002557_abnormal_social/conspecific_i | 1.77415056 |
32 | MP0006276_abnormal_autonomic_nervous | 1.77262319 |
33 | MP0002909_abnormal_adrenal_gland | 1.71188335 |
34 | MP0009780_abnormal_chondrocyte_physiolo | 1.69305860 |
35 | MP0004811_abnormal_neuron_physiology | 1.63194434 |
36 | MP0001984_abnormal_olfaction | 1.62295120 |
37 | MP0001188_hyperpigmentation | 1.62025984 |
38 | MP0008569_lethality_at_weaning | 1.54988740 |
39 | MP0003879_abnormal_hair_cell | 1.51375065 |
40 | MP0003329_amyloid_beta_deposits | 1.46535711 |
41 | MP0003122_maternal_imprinting | 1.43589949 |
42 | MP0000955_abnormal_spinal_cord | 1.39368936 |
43 | MP0008877_abnormal_DNA_methylation | 1.39238353 |
44 | MP0002066_abnormal_motor_capabilities/c | 1.37960494 |
45 | MP0002882_abnormal_neuron_morphology | 1.34989868 |
46 | MP0002102_abnormal_ear_morphology | 1.25404067 |
47 | MP0004858_abnormal_nervous_system | 1.22433815 |
48 | MP0004885_abnormal_endolymph | 1.20305947 |
49 | MP0004142_abnormal_muscle_tone | 1.20027893 |
50 | MP0001502_abnormal_circadian_rhythm | 1.18911841 |
51 | MP0000049_abnormal_middle_ear | 1.18267575 |
52 | MP0002837_dystrophic_cardiac_calcinosis | 1.17111589 |
53 | MP0003938_abnormal_ear_development | 1.15656651 |
54 | MP0002152_abnormal_brain_morphology | 1.12219654 |
55 | MP0010386_abnormal_urinary_bladder | 1.09813125 |
56 | MP0003633_abnormal_nervous_system | 1.07660739 |
57 | MP0005645_abnormal_hypothalamus_physiol | 1.06974674 |
58 | MP0008872_abnormal_physiological_respon | 1.06040220 |
59 | MP0000569_abnormal_digit_pigmentation | 1.04401214 |
60 | MP0005409_darkened_coat_color | 1.04079046 |
61 | MP0000566_synostosis | 1.01876122 |
62 | MP0006072_abnormal_retinal_apoptosis | 0.99860332 |
63 | MP0002069_abnormal_eating/drinking_beha | 0.97439687 |
64 | MP0005253_abnormal_eye_physiology | 0.97360828 |
65 | MP0002751_abnormal_autonomic_nervous | 0.97307646 |
66 | MP0000751_myopathy | 0.96658081 |
67 | MP0003631_nervous_system_phenotype | 0.94894796 |
68 | MP0002876_abnormal_thyroid_physiology | 0.94037558 |
69 | MP0002234_abnormal_pharynx_morphology | 0.92812857 |
70 | MP0004133_heterotaxia | 0.91559832 |
71 | MP0004742_abnormal_vestibular_system | 0.90423069 |
72 | MP0008874_decreased_physiological_sensi | 0.89016636 |
73 | MP0000631_abnormal_neuroendocrine_gland | 0.88888307 |
74 | MP0005499_abnormal_olfactory_system | 0.86972383 |
75 | MP0005394_taste/olfaction_phenotype | 0.86972383 |
76 | MP0004085_abnormal_heartbeat | 0.85829127 |
77 | MP0005551_abnormal_eye_electrophysiolog | 0.85274115 |
78 | MP0008789_abnormal_olfactory_epithelium | 0.84892237 |
79 | MP0001963_abnormal_hearing_physiology | 0.83259725 |
80 | MP0002653_abnormal_ependyma_morphology | 0.81598120 |
81 | MP0003119_abnormal_digestive_system | 0.81191834 |
82 | MP0001177_atelectasis | 0.80310916 |
83 | MP0005535_abnormal_body_temperature | 0.79682465 |
84 | MP0002229_neurodegeneration | 0.78190513 |
85 | MP0001664_abnormal_digestion | 0.78006521 |
86 | MP0003690_abnormal_glial_cell | 0.74854255 |
87 | MP0004145_abnormal_muscle_electrophysio | 0.72890586 |
88 | MP0004130_abnormal_muscle_cell | 0.72714386 |
89 | MP0001986_abnormal_taste_sensitivity | 0.72465447 |
90 | MP0002752_abnormal_somatic_nervous | 0.70925161 |
91 | MP0004215_abnormal_myocardial_fiber | 0.69166897 |
92 | MP0005195_abnormal_posterior_eye | 0.69125391 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.68361851 |
94 | MP0004484_altered_response_of | 0.66997753 |
95 | MP0001485_abnormal_pinna_reflex | 0.66614587 |
96 | MP0003137_abnormal_impulse_conducting | 0.65421836 |
97 | MP0000013_abnormal_adipose_tissue | 0.64047207 |
98 | MP0003634_abnormal_glial_cell | 0.63599531 |
99 | MP0003890_abnormal_embryonic-extraembry | 0.63518843 |
100 | MP0004147_increased_porphyrin_level | 0.63515668 |
101 | MP0003121_genomic_imprinting | 0.62815944 |
102 | MP0006292_abnormal_olfactory_placode | 0.61832361 |
103 | MP0003632_abnormal_nervous_system | 0.60118952 |
104 | MP0003861_abnormal_nervous_system | 0.59939950 |
105 | MP0004134_abnormal_chest_morphology | 0.59404218 |
106 | MP0002090_abnormal_vision | 0.57921024 |
107 | MP0000604_amyloidosis | 0.56909543 |
108 | MP0003283_abnormal_digestive_organ | 0.56534454 |
109 | MP0000026_abnormal_inner_ear | 0.56485480 |
110 | MP0005187_abnormal_penis_morphology | 0.55968688 |
111 | MP0003075_altered_response_to | 0.54994309 |
112 | MP0001943_abnormal_respiration | 0.53102029 |
113 | MP0002638_abnormal_pupillary_reflex | 0.51290018 |
114 | MP0005171_absent_coat_pigmentation | 0.50059563 |
115 | MP0010769_abnormal_survival | 0.48566960 |
116 | MP0002082_postnatal_lethality | 0.48459849 |
117 | MP0010770_preweaning_lethality | 0.48459849 |
118 | MP0003956_abnormal_body_size | 0.47625267 |
119 | MP0008961_abnormal_basal_metabolism | 0.46918706 |
120 | MP0000920_abnormal_myelination | 0.46070446 |
121 | MP0010768_mortality/aging | 0.45766203 |
122 | MP0003183_abnormal_peptide_metabolism | 0.44860903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 8.59878805 |
2 | Myokymia (HP:0002411) | 6.62113711 |
3 | Focal seizures (HP:0007359) | 5.90334132 |
4 | Epileptic encephalopathy (HP:0200134) | 5.27487989 |
5 | Atonic seizures (HP:0010819) | 4.77824814 |
6 | Visual hallucinations (HP:0002367) | 4.77549354 |
7 | Febrile seizures (HP:0002373) | 4.54043733 |
8 | Hyperventilation (HP:0002883) | 4.42101338 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.31851642 |
10 | Absence seizures (HP:0002121) | 4.24170535 |
11 | Dialeptic seizures (HP:0011146) | 3.98328409 |
12 | Generalized tonic-clonic seizures (HP:0002069) | 3.91340390 |
13 | Broad-based gait (HP:0002136) | 3.78894319 |
14 | Amblyopia (HP:0000646) | 3.59623572 |
15 | Gaze-evoked nystagmus (HP:0000640) | 3.46469035 |
16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.33703442 |
17 | Poor eye contact (HP:0000817) | 3.09854887 |
18 | Anxiety (HP:0000739) | 3.06811218 |
19 | Depression (HP:0000716) | 2.99195449 |
20 | Truncal ataxia (HP:0002078) | 2.98708674 |
21 | Drooling (HP:0002307) | 2.95643579 |
22 | Excessive salivation (HP:0003781) | 2.95643579 |
23 | Abnormal eating behavior (HP:0100738) | 2.94483997 |
24 | Epileptiform EEG discharges (HP:0011182) | 2.93029135 |
25 | Limb dystonia (HP:0002451) | 2.89899706 |
26 | Dysdiadochokinesis (HP:0002075) | 2.88810506 |
27 | Supranuclear gaze palsy (HP:0000605) | 2.87492660 |
28 | Progressive inability to walk (HP:0002505) | 2.87304593 |
29 | Action tremor (HP:0002345) | 2.85919313 |
30 | Dysmetria (HP:0001310) | 2.84386937 |
31 | Impaired social interactions (HP:0000735) | 2.75589609 |
32 | Abnormal social behavior (HP:0012433) | 2.75589609 |
33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.68537998 |
34 | True hermaphroditism (HP:0010459) | 2.64724307 |
35 | Hemiplegia (HP:0002301) | 2.62146531 |
36 | EEG with generalized epileptiform discharges (HP:0011198) | 2.62043280 |
37 | Abnormality of the labia minora (HP:0012880) | 2.59830849 |
38 | Diplopia (HP:0000651) | 2.57406401 |
39 | Abnormality of binocular vision (HP:0011514) | 2.57406401 |
40 | Cerebral inclusion bodies (HP:0100314) | 2.56711915 |
41 | Impaired smooth pursuit (HP:0007772) | 2.53897921 |
42 | Absent speech (HP:0001344) | 2.52698740 |
43 | Polyphagia (HP:0002591) | 2.52198581 |
44 | Nephronophthisis (HP:0000090) | 2.51237946 |
45 | Ankle clonus (HP:0011448) | 2.50544043 |
46 | Mutism (HP:0002300) | 2.50465071 |
47 | Focal dystonia (HP:0004373) | 2.49510087 |
48 | Torticollis (HP:0000473) | 2.47924481 |
49 | Fetal akinesia sequence (HP:0001989) | 2.45816385 |
50 | Hypsarrhythmia (HP:0002521) | 2.45395543 |
51 | Inability to walk (HP:0002540) | 2.44675404 |
52 | Stereotypic behavior (HP:0000733) | 2.43023755 |
53 | Hemiparesis (HP:0001269) | 2.42750530 |
54 | Abnormality of the lower motor neuron (HP:0002366) | 2.42083050 |
55 | Pancreatic fibrosis (HP:0100732) | 2.41932634 |
56 | Pendular nystagmus (HP:0012043) | 2.40982786 |
57 | Thyroid-stimulating hormone excess (HP:0002925) | 2.39112224 |
58 | Postural instability (HP:0002172) | 2.37385962 |
59 | Dysmetric saccades (HP:0000641) | 2.36648257 |
60 | Termporal pattern (HP:0011008) | 2.36562180 |
61 | Insidious onset (HP:0003587) | 2.36562180 |
62 | Bradykinesia (HP:0002067) | 2.36054147 |
63 | Pancreatic cysts (HP:0001737) | 2.34042400 |
64 | Urinary urgency (HP:0000012) | 2.32353332 |
65 | Impaired vibratory sensation (HP:0002495) | 2.30731007 |
66 | Gait imbalance (HP:0002141) | 2.30570521 |
67 | Blue irides (HP:0000635) | 2.30300414 |
68 | Papilledema (HP:0001085) | 2.29728238 |
69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.29443342 |
70 | Genetic anticipation (HP:0003743) | 2.28844914 |
71 | Protruding tongue (HP:0010808) | 2.27258914 |
72 | Pheochromocytoma (HP:0002666) | 2.23258573 |
73 | Scanning speech (HP:0002168) | 2.21282269 |
74 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20466988 |
75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19689692 |
76 | Absent/shortened dynein arms (HP:0200106) | 2.19689692 |
77 | Incomplete penetrance (HP:0003829) | 2.17679135 |
78 | Neurofibrillary tangles (HP:0002185) | 2.16307167 |
79 | Abnormal hair whorl (HP:0010721) | 2.13690339 |
80 | Agitation (HP:0000713) | 2.12067585 |
81 | Generalized myoclonic seizures (HP:0002123) | 2.11751538 |
82 | Craniofacial dystonia (HP:0012179) | 2.10674372 |
83 | Spastic gait (HP:0002064) | 2.09026752 |
84 | Annular pancreas (HP:0001734) | 2.09025639 |
85 | Delusions (HP:0000746) | 2.07672578 |
86 | Molar tooth sign on MRI (HP:0002419) | 2.02479202 |
87 | Abnormality of midbrain morphology (HP:0002418) | 2.02479202 |
88 | Status epilepticus (HP:0002133) | 2.01174388 |
89 | Abnormality of the corticospinal tract (HP:0002492) | 2.00357178 |
90 | Abnormality of salivation (HP:0100755) | 1.99838643 |
91 | Intention tremor (HP:0002080) | 1.99207261 |
92 | Specific learning disability (HP:0001328) | 1.96744620 |
93 | Megalencephaly (HP:0001355) | 1.94572474 |
94 | Split foot (HP:0001839) | 1.94039391 |
95 | Neuroendocrine neoplasm (HP:0100634) | 1.93899640 |
96 | Amyotrophic lateral sclerosis (HP:0007354) | 1.93733642 |
97 | Optic nerve hypoplasia (HP:0000609) | 1.91647737 |
98 | Congenital primary aphakia (HP:0007707) | 1.91237729 |
99 | Vaginal atresia (HP:0000148) | 1.90766303 |
100 | Genital tract atresia (HP:0001827) | 1.89333292 |
101 | Decreased central vision (HP:0007663) | 1.88595429 |
102 | Septo-optic dysplasia (HP:0100842) | 1.87824390 |
103 | Medial flaring of the eyebrow (HP:0010747) | 1.87707702 |
104 | Dyskinesia (HP:0100660) | 1.86621317 |
105 | Thickened helices (HP:0000391) | 1.86431586 |
106 | Psychosis (HP:0000709) | 1.85208084 |
107 | Failure to thrive in infancy (HP:0001531) | 1.84753151 |
108 | Hypothermia (HP:0002045) | 1.84331875 |
109 | Gait ataxia (HP:0002066) | 1.84094190 |
110 | Hyperthyroidism (HP:0000836) | 1.83740956 |
111 | Abnormality of the renal medulla (HP:0100957) | 1.83117272 |
112 | Lower limb muscle weakness (HP:0007340) | 1.81539853 |
113 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.80701176 |
114 | Cutaneous finger syndactyly (HP:0010554) | 1.80472710 |
115 | Sleep apnea (HP:0010535) | 1.79374190 |
116 | Lower limb asymmetry (HP:0100559) | 1.79352550 |
117 | Chronic hepatic failure (HP:0100626) | 1.79109862 |
118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78781995 |
119 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78781995 |
120 | Resting tremor (HP:0002322) | 1.78648048 |
121 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78623414 |
122 | Type II lissencephaly (HP:0007260) | 1.78137812 |
123 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.77461061 |
124 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77425682 |
125 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77425682 |
126 | Generalized hypopigmentation of hair (HP:0011358) | 1.77026588 |
127 | Autism (HP:0000717) | 1.75983441 |
128 | Abnormal ciliary motility (HP:0012262) | 1.75493264 |
129 | Retinal dysplasia (HP:0007973) | 1.74857489 |
130 | Hydroureter (HP:0000072) | 1.74219007 |
131 | Esotropia (HP:0000565) | 1.73336846 |
132 | Cystic liver disease (HP:0006706) | 1.73096790 |
133 | Heterochromia iridis (HP:0001100) | 1.73009903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.25749136 |
2 | NTRK3 | 4.58604790 |
3 | MAP3K9 | 3.15451264 |
4 | MAP3K4 | 3.11623351 |
5 | MAP3K12 | 2.92275011 |
6 | MARK1 | 2.90199726 |
7 | MAP2K7 | 2.84113816 |
8 | CASK | 2.75203993 |
9 | RIPK4 | 2.54722963 |
10 | MINK1 | 2.48409302 |
11 | DAPK2 | 2.14385575 |
12 | KSR1 | 2.06329922 |
13 | FRK | 2.06019803 |
14 | MAP2K4 | 1.96745933 |
15 | PLK2 | 1.93526196 |
16 | DAPK1 | 1.92957106 |
17 | PRPF4B | 1.88040464 |
18 | KSR2 | 1.81366917 |
19 | CDK19 | 1.79618514 |
20 | NTRK2 | 1.73629154 |
21 | PAK6 | 1.67968658 |
22 | ARAF | 1.63701455 |
23 | PNCK | 1.63307449 |
24 | TNIK | 1.49000786 |
25 | CDK5 | 1.45021669 |
26 | MAPK13 | 1.43803662 |
27 | SIK2 | 1.41554001 |
28 | DYRK2 | 1.41058083 |
29 | SIK3 | 1.40611227 |
30 | MAP4K2 | 1.37173295 |
31 | GRK1 | 1.32756226 |
32 | CAMKK1 | 1.31506552 |
33 | GRK5 | 1.29394811 |
34 | BMPR2 | 1.29244101 |
35 | PRKCG | 1.26015103 |
36 | PTK2B | 1.25827459 |
37 | FES | 1.22327515 |
38 | NME1 | 1.18027990 |
39 | CAMK2A | 1.16536379 |
40 | PRKD3 | 1.13111225 |
41 | CAMK2B | 1.12390629 |
42 | MAP3K13 | 1.09944135 |
43 | NTRK1 | 1.05997621 |
44 | MAPKAPK5 | 1.04659263 |
45 | MKNK2 | 1.03310898 |
46 | PKN1 | 1.02878372 |
47 | FGFR2 | 1.00653622 |
48 | OXSR1 | 1.00056068 |
49 | CSNK1G1 | 0.97188039 |
50 | CDK18 | 0.95750525 |
51 | RAF1 | 0.94150072 |
52 | CSNK1G3 | 0.93109748 |
53 | BCR | 0.90117578 |
54 | SGK223 | 0.87749193 |
55 | SGK494 | 0.87749193 |
56 | CDK14 | 0.87623260 |
57 | TRIM28 | 0.87225189 |
58 | FGR | 0.87107926 |
59 | CDK15 | 0.87085812 |
60 | BMPR1B | 0.86497886 |
61 | CSNK1A1L | 0.85104396 |
62 | UHMK1 | 0.84652541 |
63 | MAP3K2 | 0.83230629 |
64 | SGK2 | 0.82713105 |
65 | CAMKK2 | 0.80197794 |
66 | AKT3 | 0.79060283 |
67 | INSRR | 0.77383056 |
68 | STK38 | 0.77169915 |
69 | CDK11A | 0.74774242 |
70 | DYRK1A | 0.71530919 |
71 | TYRO3 | 0.71330300 |
72 | SGK1 | 0.71218581 |
73 | CAMK4 | 0.68695963 |
74 | CSNK1G2 | 0.65728319 |
75 | CAMK1 | 0.65393207 |
76 | CCNB1 | 0.61871741 |
77 | MAPK15 | 0.61693277 |
78 | BRAF | 0.60492037 |
79 | CSNK1A1 | 0.59672111 |
80 | MAP3K6 | 0.59583675 |
81 | LATS2 | 0.59226927 |
82 | STK11 | 0.58559777 |
83 | RET | 0.56037949 |
84 | PAK3 | 0.55174277 |
85 | PHKG2 | 0.54872002 |
86 | PHKG1 | 0.54872002 |
87 | GRK7 | 0.53836150 |
88 | PDK1 | 0.53284462 |
89 | PRKCE | 0.53019927 |
90 | SGK3 | 0.51137895 |
91 | WNK3 | 0.50812863 |
92 | PINK1 | 0.50625809 |
93 | MARK2 | 0.50508313 |
94 | PDPK1 | 0.49667506 |
95 | EPHA3 | 0.48963761 |
96 | ADRBK2 | 0.48392412 |
97 | CAMK2D | 0.47213236 |
98 | PRKCH | 0.45920334 |
99 | MKNK1 | 0.45895517 |
100 | FER | 0.45367351 |
101 | PRKCZ | 0.45290457 |
102 | MAP3K1 | 0.43357408 |
103 | TNK2 | 0.43293339 |
104 | ERBB2 | 0.43266977 |
105 | CAMK2G | 0.43171101 |
106 | CSNK1D | 0.42747773 |
107 | MAP2K1 | 0.42323199 |
108 | RPS6KA3 | 0.39599509 |
109 | FYN | 0.38501404 |
110 | BCKDK | 0.37471469 |
111 | BRSK1 | 0.37086030 |
112 | PRKCA | 0.36641389 |
113 | GRK6 | 0.35324490 |
114 | ACVR1B | 0.35286377 |
115 | PRKG1 | 0.35201341 |
116 | NUAK1 | 0.34887864 |
117 | ADRBK1 | 0.33817796 |
118 | TAOK2 | 0.32793290 |
119 | TSSK6 | 0.32314478 |
120 | ERBB3 | 0.31468226 |
121 | MAPK8 | 0.31236165 |
122 | DAPK3 | 0.31159544 |
123 | PRKCB | 0.31016857 |
124 | MAPK10 | 0.30431120 |
125 | PRKACA | 0.28685477 |
126 | PLK3 | 0.28475044 |
127 | CSNK1E | 0.28374937 |
128 | NEK6 | 0.27857074 |
129 | ROCK2 | 0.27794041 |
130 | PRKD2 | 0.27619002 |
131 | RPS6KA2 | 0.26949398 |
132 | ZAK | 0.26460488 |
133 | PRKACB | 0.25875403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.28819600 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.17453355 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.97064260 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87012105 |
5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.85932709 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81857269 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.76615814 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.69246326 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68956963 |
10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.67442704 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.39753539 |
12 | Salivary secretion_Homo sapiens_hsa04970 | 2.18448090 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08585799 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95549322 |
15 | Taste transduction_Homo sapiens_hsa04742 | 1.95406975 |
16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.92363278 |
17 | Renin secretion_Homo sapiens_hsa04924 | 1.89492219 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86561693 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82893466 |
20 | Insulin secretion_Homo sapiens_hsa04911 | 1.82525608 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.78338484 |
22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.77271050 |
23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73549109 |
24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.73373598 |
25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63135946 |
26 | Gap junction_Homo sapiens_hsa04540 | 1.45945726 |
27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.45776006 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44772871 |
29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.35008659 |
30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29001717 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26531458 |
32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26061277 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25845177 |
34 | Axon guidance_Homo sapiens_hsa04360 | 1.19833291 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15613259 |
36 | Glioma_Homo sapiens_hsa05214 | 1.09026815 |
37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06760431 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06093058 |
39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04795814 |
40 | Melanogenesis_Homo sapiens_hsa04916 | 1.02784572 |
41 | Phototransduction_Homo sapiens_hsa04744 | 1.02538430 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02242370 |
43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01909909 |
44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98347243 |
45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98001810 |
46 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95881987 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95210673 |
48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90603570 |
49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87962796 |
50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87885751 |
51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85940787 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85698895 |
53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81083256 |
54 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75141210 |
55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74031576 |
56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73832941 |
57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72339271 |
58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70645422 |
59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70593899 |
60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69809529 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69333300 |
62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69207322 |
63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67359088 |
64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67007272 |
65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64914065 |
66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64226646 |
67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63810882 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62659358 |
69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61529159 |
70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61366616 |
71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60997034 |
72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60609781 |
73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60321660 |
74 | Alcoholism_Homo sapiens_hsa05034 | 0.59782585 |
75 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59268714 |
76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57794195 |
77 | Bile secretion_Homo sapiens_hsa04976 | 0.56123151 |
78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54398392 |
79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53429121 |
80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52989844 |
81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50637774 |
82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49762171 |
83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49078863 |
84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48839510 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48812353 |
86 | ABC transporters_Homo sapiens_hsa02010 | 0.47060375 |
87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45753044 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45382636 |
89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45112115 |
90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45029389 |
91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44920438 |
92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44620157 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44289354 |
94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43272757 |
95 | Mineral absorption_Homo sapiens_hsa04978 | 0.42654744 |
96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42351315 |
97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41734913 |
98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41584786 |
99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39379120 |
100 | Prion diseases_Homo sapiens_hsa05020 | 0.39255293 |
101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39215329 |
102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38629620 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38087515 |
104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37080648 |
105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37008303 |
106 | Protein export_Homo sapiens_hsa03060 | 0.33725438 |
107 | Melanoma_Homo sapiens_hsa05218 | 0.33085654 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32821041 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31715785 |
110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31607893 |
111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31297184 |
112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.30428820 |
113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30091207 |
114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29952790 |
115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29182274 |
116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28430172 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27934288 |
118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26888711 |
119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25648809 |
120 | Endocytosis_Homo sapiens_hsa04144 | 0.24718375 |
121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24147041 |
122 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.23794760 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23238961 |
124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22498474 |
125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20280384 |